We are live on ! Find out more
SPAN

Span-America Medical Systems I
SPAN

Delisted

SPAN was delisted on the 16th of June, 2017.

0 hedge funds and large institutions have $0 invested in Span-America Medical Systems I in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 10 (-1)

100% less capital invested

Capital invested by funds: $26K → $0 (-$26K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
Holders Change
-1
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
MDCM
1
Morgan Dempsey Capital Management
Wisconsin
-$26K -1,430 Closed

SPAN Hedge Fund Activity: Q4 2017 in Review

0 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Span-America Medical Systems I (SPAN) for Q4 2017, worth a combined $0 — down 100% from $26K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of SPAN and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Morgan Dempsey Capital Management, exiting entirely with an estimated $26K sold.

  • 0 institutional investors held Span-America Medical Systems I (SPAN) as of Q4 2017, down from 1 in Q3 2017.
  • Funds reported $0 of Span-America Medical Systems I stock for Q4 2017, down 100% quarter-over-quarter.
  • 0 funds opened new Span-America Medical Systems I positions in Q4 2017 and 1 closed out, a net change of -1 holder.
  • The largest Span-America Medical Systems I seller in Q4 2017 was Morgan Dempsey Capital Management, an estimated $26K sold.

Based on aggregated 13F filings for Q4 2017.